STOCKS TELEGRAPH

Author: ST Staff

  • Is There Any Reason As To Why The ARRPY Stock Expanded By 19%?

    Aeroports de Paris SA [OTCPink: ARRPY] stock was booming at the previous close as it surged 19.05% to $13.00. Aeroports de Paris stock recorded volume of 310 shares against the 30-day Average Volume of 259 shares. During the last 52-week period ARRPY stock value ranged from $9.75 to$15.50. ARRPY stock surged on release of a traffic update.

    Which traffic update was it?

    Aeroports de Paris develops and manages several airports in the Paris area, including Charles de Gaulle, Orly and Le Bourget. ARRPY this week issued a traffic update, which is as follows:

    • During that period, ARRPY welcomed about 7.1 million passengers to its network of airports.
    • ARRPY’s April 2021 figure represents 25.7% of its April 2019 traffic.
    • In April 2021, the number of passengers passing through ARRPY’s Paris Aéroport by increased by 1.2 million compared to April 2020, with 1.3 million passengers passing through ARRPY.
    • It accounts for 13.9% of Paris Aéroport traffic in April 2019.
    • In April 2021, Paris-Charles de Gaulle of Aeroports de Paris (ARRPY) welcomed 0.9 million passengers, an increase of +0.8 million passengers or 14.1% over April 2019.
    • Paris-Orly received 0.4 million passengers in April 2021, up 13.4% from April 2019.

    What ARRPY delivered?

    At Paris-Charles de Gaulle and Paris-Orly, ARRPY handled more than 33.1 million passengers in 2020, and more than 1.8 million metric tons of cargo and mail abroad. Aeroports de Paris (ARRPY) boasted an exceptional location and catchment area, and is continuously striving to upgrade quality of services and modernize terminal facilities. Total passengers at the ARRPY rose by 6.8 million from April 2020 to April 2021.

  • Is Ynvisible (YNVYF) Stock Set To Rise Further?

    A share of Ynvisible Interactive Inc (OTCQB: YNVYF) closed up 22.49 percent to $0.5686 in the previous session. At the close, 84.30K shares of Ynvisible stock exchanged hands between a price range of $0.5187 and $0.5686. As a result of the private placement, YNVYF stock shot up.

    An overview of private placement:

    Ynvisible aims to be a leader in the expanding printed and flexible electronics market. Since printed electronics are both cheaper and power-efficient than traditional electronics, they are key enablers of mass adoption of the Internet of Things (“IoT”) and smart objects. Electrochromic materials, inks, and systems are a specialized area in which YNVYF excels.

    In addition to interactive printed graphics, YNVYF offers low-power, mass-deployable, and easy-to-use electronic displays and indicators for everyday smart objects, Internet of Things devices, and ambient intelligence (intelligent surfaces).

    The closing of the private placement of Ynvisible common shares and warrants to purchase Common Shares to institutional investors was announced today.

    • The YNVYF received gross proceeds of approximately Cdn$12 million from the private placement.
    • A Private Placement was undertaken by YNVYF, whereby the company issued 19,992,003 Common Shares and warrants to purchase 19,992,003 Common Shares of YNVYF stock at a purchase price of Cdn$0.61.
    • An exercise price of $0.76 per Common Share applies to each YNVYF Warrant; the holder may exercise the Warrant prior to or on May 18, 2024.
    • Exclusive placement agent Alliance Global Partners handled the private placement for YNVYF in the United States.

    What does CEO say?

    Michael Robinson, CEO of Ynvisible, said that the private placement:

    • Is the largest private placement to date.
    • Will allow YNVYF continue investing in and developing its technology.
    • Will help Ynvisible (YNVYF) develop value-added IoT solutions that will benefit its customers.
    • Will improve YNVYF’s relationship with US-based customers and shareholders, as well.

  • Why Did AWSL Stock Gain 34%?

    The stock of Atlantic Power & Infrastructure Corp. (OTCPink-AWSL) soared impressively, rising a whopping 34.15% to $0.1100 at the previous close. On a weekly basis, Atlantic Power & Infrastructure stock price was 18.92% higher, and on a monthly basis, it was 24.29% higher. As an AWSL product was specified for an eco-friendly infrastructure project, the AWSL stock rose.

    What is that project?

    Globally, Atlantic Power & Infrastructure develops power and infrastructure projects based on renewable energy. AWSL manufactures and distributes porous flexible pavements through its recently acquired K.B. Industries. At the same time, AWSL is actively developing projects to convert municipal solid waste (MSW) and biomass waste (agriculture, yard, food, and raw sewage) into pellets.

    The Atlanta Beltline Walkway and Bicycle Path will feature KBI Flexi-Pave, according to news from Atlantic Power.

    • KBI’s Flexi-Pave has been tested extensively over the past five years on the Atlanta Beltline and has proven to be the better alternative.
    • Approximately 33,000 feet of Walkway and Bicycle Path will be widened by an average of 2 feet by adding KBI Flexi-Pave while existing Asphalt paths will be preserved.
    • With this project, the Beltline will experience less erosion, preventing water from flowing off the asphalt sides during a storm and eroding the subbase underneath, causing costly failures and damage to the sides of the pavement.

    Acknowledgment for AWSL:

    The KBI Flexi-Pave uses recycled tire granules together with aggregates and a proprietary binding agent to create a totally benign, ecologically responsible porous paving product. Furthermore, its use in Beltline confirms Atlantic Power (AWSL)’s a commitment to pursuing sustainable solutions.

  • What Motivated QUBT Stock To Climb 39%?

    Shares of the leader in bridging the power of classic and quantum computing Quantum Computing, Inc [OTCQB: QUBT] surged 39.23% during the previous session, closing at $6.8500. The daily volume of Quantum Computing stock was 462.13K versus the 30-day average of 103.17K. The QUBT stock price ranged from $0.8310 to $25.070 in the last 52 weeks. As quantum software was applied across many business segments, QUBT stock rose.

    How QUBT applied the software?

    Quantum computing develops quantum-based business solutions by accelerating its value. With the launch of Qatalyst, QUBT’s flagship product, SMEs can resolve complex computational problems without exposing their complexity.

    Quantum Computing announced last week it was collaborating with major firms on quantum applications tailored to various industries. Quantum-driven solutions to current problems are being defined, created, and tested by QUBT in collaboration with subject matter experts and market leaders participating in the program.

    The following use cases are under development:

    • Leading data analytics firm on online fraud detection and physical access to secure sites using quantum technology, specifically detecting fraudulent activity on credit cards.
    • After the recent Colonial Pipeline ransomware cyber-attack, a global oil company is focusing on optimizing oil supply chains as well as pipeline cyber security.
    • An international company working on intelligent routing and distribution optimization, as well as robotic automation for logistical order fulfillment, explores quantum opportunities in these areas.
    • An accounting and auditing company is investigating the possibility of scaling up quantum computing capabilities to assess risk and optimize complex business processes.
    • Quantum computing is being used by an innovative pharmaceutical company to optimize drug trials, diagnostics, and treatment options.

    Major Player:

    QUBT’s QikStart program, which aims to foster and develop practical applications of Qatalyst, the company’s quantum application accelerator, is the driving force behind these joint efforts. With the launch of QikStart earlier this year, Quantum Computing (QUBT) initiative has attracted the attention and participation of companies seeking to adopt quantum computing techniques in order to solve mission-critical problems today and in the future.

  • American CryoStem (CRYO) Stock Risen 50%. Does It Hold A Huge Advantage?

    The clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies American CryoStem Corporation (OTCPink: CRYO) rose 50.86% to $0.4980 during yesterday’s trading. American CryoStem stock traded 11,890 shares compared with its average 30-day volume of 31,335. The signing of a letter of intent (LOI) for a clinical study boosted the CRYO stock.

    What was that LOI signed for?

    American CryoStem is developing and licensing new technologies for cell therapy, including therapies using autologous stem cells. CRYO provides its patients with a best-in-class, end-to-end cellular therapy solution with our centralized laboratory model and patent-pending “CryoStem Platform”. CRYO creates personalized adipose-derived mesenchymal stem cell therapies directly at the point of care using adipose-tissue scar tissue and cryopreservation at ATCELL Bank.

    The American CryoStem company announced in this month that it had signed a LOI with Tinton Falls, NJ’s Advanced Regenerative Associates, LLC (“ARA”).

    • CRYO had signed the LOI for the development of a cell-based wound covering product for nonhealing wounds, skin ulcers, and peripheral ischemia caused by type II diabetes, burns, and other systemic disorders.
    • ARA is dedicated to developing a range of cellular therapy products and devices under the direction of Dr. Michael J. DeMarco.
    • Diabetes wounds and skin ulcers that do not respond to current standards of care are treated and mitigated with the products developed by ARA.

    Will it be an opportunity for CRYO?

    American CryoStem (CRYO) sees a huge market opportunity in the development of cellular therapy products and treatments. A number of CRYO’s efforts are geared toward addressing diseases, disorders, and muscle-skeletal injuries with multi-billion dollar treatment markets, such as using the “CryoStem Platform” and centralized laboratory manufacturing methodologies. As part of that strategy, CRYO’s current move fits in.

  • Were There Any Significant Reasons Why The Green Globe (GGII) Stock Increased 53%?

    The share price of Green Globe International, Inc (OTCPink: GGII) closed Tuesday’s trading session at $0.0895, up 53.78 percent versus the previous day’s close of $0.0582. During the last month, shares of Green Globe Stock soared by over 3480.00%; the volume for the month averaged over 501.71M shares. The GGII stock rose despite the absence of current news, so it is possible to gain insight from recent developments regarding GGII.

    What happened at GGII recently?

    Green Globe offers CBD-infused products to companies that offer consumer goods. GGII is a direct conduit between industrial hemp growers and processors and consumer product manufacturers for CBD oils. Furthermore, GGII provides fulfillment services, including specialized storage and shipping, to CBD-based products developers, such as edibles and topical presentations.

    According to the latest disclosure by Green Globe, the control of GGII was transferred to The Hempacco Co., Inc. in March 2021, due to a private sale of 100 Series A Preferred Shares of GGII.

    • New directors for GGII were chosen, led by Hempacco executive Sandro Piancone.
    • In addition, GGII applied at OTC Markets Group, Inc. for access to its information and disclosure system so that it could fill in missing reports and add more details about the new ownership group.
    • About three to four weeks are needed to complete the process.
    • Using plant-based products – natural smokables such as herb cigarettes, CBD, CBG, and hemp cigarettes – Hempacco is disrupting the tobacco industry.

    What can we expect next from GGII?

    Green Globe (GGII) expects to pursue a merger or combination transaction with Hempacco as soon as it has met its OTC Markets filing obligations. But, GGII and Hempacco have yet to sign a definitive agreement, and no guarantee has been given that such an agreement will be signed nor that a combination will be enacted.

  • Which Factors Led To The 54% Rise In CareView (CRVW) Stock?

    In trading on Tuesday, CareView Communications, Inc. (OTCQB: CRVW), an information technology provider to the healthcare industry, gained 54.17 percent to $0.1850. Trading range for CareView stock has been $0.1720 to $0.1850. Recent developments might shed some light on the CRVW stock whose price was on the rise despite a lack of current news.

    What’s been going on lately?

    Providing digital video monitoring solutions to hospitals and health facilities across the country, CareView is revolutionizing patient safety. Over the last decade, CRVW has relentlessly pursued innovative ways to better protect patients, developing solutions that lower operational costs and enhance safety within the hospital environment. CRVW’s innovative technology installed in over 150 hospitals has shown that patient safety has increased with 80% fewer falls and 65% fewer sitter costs.

    In last month’s update, CareView said that new sales-based contracts were fully contracted for the fourth quarter of 2020, bringing the total contract sales price to $1,800,000. Most of CRVW’s contracts include a combination of products, software solutions, and services that can be paid for in various ways.

    CRVW’s recently implemented sales-based contract model with auto-renewal has enabled some customers to lease equipment using CareView’s subscription model, while others purchase it up front under the company’s subscription model.

    CRVW’s further expectations:

    In fiscal year 2021, CRVW anticipates that sales and service-based contracts will be the most common type of new contract. In recent months, CareView (CRVW) has been hearing from an increasing number of VA hospitals about future contracts and anticipates that number to increase throughout 2021.

  • What Caused TraQiQ (TRIQ) Stock To Rise Nearly 65%?

    Last session, the stock of leading provider of technology solutions TraQiQ Inc (OTCQB: TRIQ) closed at $1.6800, up 64.71%. During the session, the TraQiQ stock price fluctuated between $1.1600 and $1.6800. TRIQ stock surged after it entered into an acquisition deal.

    The deal was for what?

    TraQiQ Inc. is a global technology company specializing in tools for identifying customers, facilitating and fulfilling transactions. In addition to increasing customer loyalty, improving profitability, and driving efficient financial transactions, TRIQ’s leading-edge FinTech and AI solutions are being utilized across leading multi-national companies around the world.

    In a company announcement last week, TraQiQ said it had signed a non-binding Letter of Intent to acquire Ascent Business Technology.

    • With locations in Singapore, Dubai, India, and North America, Ascent offers a wide range of Fintech solutions to the Enterprise market.
    • Cloud-based software solution provider Ascent helps companies manage financial risk, control, and resilience.
    • Ascent’s robust platform used with this solution provides intelligent insights based on machine learning and artificial intelligence.
    • Offerings by Ascent include financial reconciliation products, regulatory reporting tools, and resilience software for enterprises.

    How will the deal benefit TRIQ?

    The geographic reach of Ascent will enable TraQiQ (TRIQ) to reach a global audience. Revenue at TRIQ increased by over 30% in Q1 compared to the previous quarter. TRIQ expects its revenue run-rate to be $20M by the end of the current year with the acquisition of Ascent and its current growth plans.

  • Do You Know Why WOWI Stock Has Increased 69%?

    Metro One Telecommunications, Inc. (OTCPINK: WOWI) recorded significant gains during the previous session as it rose 68.95% to $0.2198 at close. Last week, Metro One stock returned 46.53%, compared to 63.06% over the past month.

    Since WOWI stock rose when no current news was available, there may be some basis for believing recent developments will provide additional information about WOWI.

    What has recently occurred at WOWI?

    Metro One specializes in call center and data management services. In addition to inbound and outbound contact centers, WOWI provides data and analytics as well as other services. Based in Beaverton, Oregon, WOWI was founded in 1989.

    Stratford Ltd., an Israel-based wholly owned subsidiary of Metro One, recently closed a $3.5 million financing round and acquired Royal App Ltd.

    • The financing was provided by institutional investors and family offices through puttable Simple Agreements for Future Equity (“SAFE”).
    • In order to acquire some assets, Stratford received notification that its winning bid was approved by the Lod District Court.
    • In addition to those assets, there is intellectual property from Royal App Ltd. (out of insolvency proceedings) worth approximately $2.4 million in cash in addition to equity in Metro One.
    • WOWI was able to finance and acquire Royal App as well as inject working capital into Royal App as a result of the financing.

    What WOWI will be getting?

    WOWI will be building on the artificial intelligence technology developed by Royal App, which has been praised by customers internationally. By acquiring Royal App, Metro One (WOWI) will be able to benefit from an exciting advanced technology business.

  • What Is Driving The Eurofins (ERFSF) Stock Higher In Early Trades?

    What Is Driving The Eurofins (ERFSF) Stock Higher In Early Trades?

    Shares of Eurofins Scientific S.E. (OTCPink: ERFSF) have been trending upward in the early trades today. Eurofins stock closed the last session up 7.02 percent at $101.40, ranging from $97.00 to $104.27. Over the past month, ERFSF stock fell over -5.67%, with approximately 3.79K shares traded daily.

    ERFSF stock has gained more than 61.65% in the past 12 months reaching a high of $112.50, valuing the company at $18.05B. Following the news that ERFSF stock had developed new detection and identification products, the ERFSF stock rose.

    What were those products?

    Testing for Life is Eurofins’ mission. In addition to more than 50,000 employees across over 800 laboratories in over 50 countries, ERFSF’s firms offer more than 200,000 different analytical methods.

    A wide range of COVID-19 diagnostic products are being developed by ERFSF stock, especially in response to the danger of emerging mutations. ERFSF yesterday announced the launch of two new products:

    1. GSD NovaPrime Plus SARS-CoV-2
    2. GSD NovaType Select L452R SARS-CoV-2 (RUO)

    A PCR test such as GSD NovaPrime Plus SARS-CoV-2 can detect major mutations in a variant, such as in the UK variant, in just one reaction.

    The new test of its kind, GSD NovaType Select L452R SARS-CoV-2 (RUO), on the other hand, enables detection of critical variants, such as those found in India, the United States, and California.

    ERFSF going forward:

    Eurofins (ERFSF) stock has continued to invest in R&D to develop reliable, high-quality testing solutions for the SARS-CoV-2 virus and its variants, which is evident in these two new products that will not only benefit consumers but also the company as well.